Hogan V - Search Results

1

Regulation of phosphoglucose isomerase/autocrine motility factor expression by hypoxia.

Funasaka T, Yanagawa T, Hogan V, Raz A. Funasaka T, et al. Among authors: hogan v. FASEB J. 2005 Sep;19(11):1422-30. doi: 10.1096/fj.05-3699com. FASEB J. 2005. PMID: 16126909

2

Purification of B16-F1 melanoma autocrine motility factor and its receptor.

Silletti S, Watanabe H, Hogan V, Nabi IR, Raz A. Silletti S, et al. Among authors: hogan v. Cancer Res. 1991 Jul 1;51(13):3507-11. Cancer Res. 1991. PMID: 1647268

3

Purification of human tumor cell autocrine motility factor and molecular cloning of its receptor.

Watanabe H, Carmi P, Hogan V, Raz T, Silletti S, Nabi IR, Raz A. Watanabe H, et al. Among authors: hogan v. J Biol Chem. 1991 Jul 15;266(20):13442-8. J Biol Chem. 1991. PMID: 1649192 Free article.

4

Molecular cloning and chromosomal mapping of a human galactoside-binding protein.

Raz A, Carmi P, Raz T, Hogan V, Mohamed A, Wolman SR. Raz A, et al. Among authors: hogan v. Cancer Res. 1991 Apr 15;51(8):2173-8. Cancer Res. 1991. PMID: 2009535

5

Evidence for the role of 34-kDa galactoside-binding lectin in transformation and metastasis.

Raz A, Zhu DG, Hogan V, Shah N, Raz T, Karkash R, Pazerini G, Carmi P. Raz A, et al. Among authors: hogan v. Int J Cancer. 1990 Nov 15;46(5):871-7. doi: 10.1002/ijc.2910460520. Int J Cancer. 1990. PMID: 2228316

6

Inhibition of spontaneous metastasis in a rat prostate cancer model by oral administration of modified citrus pectin.

Pienta KJ, Naik H, Akhtar A, Yamazaki K, Replogle TS, Lehr J, Donat TL, Tait L, Hogan V, Raz A. Pienta KJ, et al. Among authors: hogan v. J Natl Cancer Inst. 1995 Mar 1;87(5):348-53. doi: 10.1093/jnci/87.5.348. J Natl Cancer Inst. 1995. PMID: 7853416

7

Structure-function relationship of a recombinant human galactoside-binding protein.

Ochieng J, Platt D, Tait L, Hogan V, Raz T, Carmi P, Raz A. Ochieng J, et al. Among authors: hogan v. Biochemistry. 1993 Apr 27;32(16):4455-60. doi: 10.1021/bi00067a038. Biochemistry. 1993. PMID: 8476870

8

The NH2 terminus of galectin-3 governs cellular compartmentalization and functions in cancer cells.

Gong HC, Honjo Y, Nangia-Makker P, Hogan V, Mazurak N, Bresalier RS, Raz A. Gong HC, et al. Among authors: hogan v. Cancer Res. 1999 Dec 15;59(24):6239-45. Cancer Res. 1999. PMID: 10626818

9

Galectin-3 induces endothelial cell morphogenesis and angiogenesis.

Nangia-Makker P, Honjo Y, Sarvis R, Akahani S, Hogan V, Pienta KJ, Raz A. Nangia-Makker P, et al. Among authors: hogan v. Am J Pathol. 2000 Mar;156(3):899-909. doi: 10.1016/S0002-9440(10)64959-0. Am J Pathol. 2000. PMID: 10702407 Free PMC article.

10

Decreased galectin-3 expression in prostate cancer.

Pacis RA, Pilat MJ, Pienta KJ, Wojno K, Raz A, Hogan V, Cooper CR. Pacis RA, et al. Among authors: hogan v. Prostate. 2000 Jul 1;44(2):118-23. doi: 10.1002/1097-0045(20000701)44:2<118::aid-pros4>3.0.co;2-u. Prostate. 2000. PMID: 10881021 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

163 results

Search Page

Filters